Newswise Feature Channel: Clinical Trials /articles/channels/Clinical Trials This [feature]/[breaking news]/[focus] channel highlights experts, research, and feature stories related to... en-us Copyright 2024 Newswise Newswise Feature Channel: Clinical Trials 115 31 / /images/newswise-logo-rss.gif New Atrial Fibrillation Treatment Gets Dad His Beat Back /articles/new-atrial-fibrillation-treatment-gets-dad-his-beat-back/?sc=c6502 /articles/new-atrial-fibrillation-treatment-gets-dad-his-beat-back/?sc=c6502 Tue, 11 Jun 2024 12:05:55 EST Cardiovascular Health,Clinical Trials,Government and Law,Health Disparities,Healthcare,Heart Disease Medical News Feature <img src="/legacy/image.php?image=https://content.presspage.com/uploads/2110/fcd51847-8fe0-4584-88f9-05f83af7beae/1920_nieminen1.jpeg?10000&width=100&height=150" alt="Newswise image" />Everyone knows exhaustion is a rite of passage for new parents, which is why Henric Nieminen ignored the symptoms at first. /articles/https://content.presspage.com/uploads/2110/fcd51847-8fe0-4584-88f9-05f83af7beae/1920_nieminen1.jpeg?10000,https://content.presspage.com/uploads/2110/b243731c-5940-439c-a4d1-43a5864d0683/800_9302-hi-epofdr.albert-001.jpg?x=1718056213129,https://content.presspage.com/uploads/2110/e4d83b29-73ef-4874-b8de-9a44109a7c1f/800_30780-hi--michaelshehata5.jpg?x=1718056256001 Cedars-Sinai Discovery in hibernating animals could extend the shelf life of cells and tissues for transplantation   /articles/discovery-in-hibernating-animals-could-extend-the-shelf-life-of-cells-and-tissues-for-transplantation/?sc=c6502 /articles/discovery-in-hibernating-animals-could-extend-the-shelf-life-of-cells-and-tissues-for-transplantation/?sc=c6502 Tue, 11 Jun 2024 12:05:40 EST All Journal News,Cell Biology,Clinical Trials,Government and Law,Transplantation,Nature (journal),National Institutes of Health (NIH),National Eye Institute (NEI) Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2024/06/11/666878980bdf1_transplantedislets.jpg&width=100&height=150" alt="Newswise image" />Research led by scientists at the National Eye Institute and Sun Yat-sen University, Guangzhou, China points to a potential strategy for extending the cold storage shelf life of donor cells and tissues, such as those of the pancreas, an organ crucial for making insulin. /articles//images/uploads/2024/06/11/666878980bdf1_transplantedislets.jpg NIH, National Eye Institute (NEI) Team tests strategies to care for patients with multiple diseases /articles/team-tests-strategies-to-care-for-patients-with-multiple-diseases/?sc=c6502 /articles/team-tests-strategies-to-care-for-patients-with-multiple-diseases/?sc=c6502 Tue, 11 Jun 2024 10:05:29 EST All Journal News,Cardiovascular Health,Clinical Trials,Diabetes,Health Disparities,Healthcare,Kidney Disease,Public Health,NEJM Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2024/06/11/6668663c9d2ef_m-vazquez.jpg&width=100&height=150" alt="Newswise image" />In a large clinical trial, UT Southwestern Medical Center researchers developed a robust model for testing strategies to prevent health problems in patients with multiple chronic conditions. /articles//images/uploads/2024/06/11/6668663c9d2ef_m-vazquez.jpg,/images/uploads/2024/06/11/666866657eb0f_toto-robert.jpg UT Southwestern Medical Center Multicenter clinical study supports safety of deep general anesthesia /articles/multicenter-clinical-study-supports-safety-of-deep-general-anesthesia/?sc=c6502 /articles/multicenter-clinical-study-supports-safety-of-deep-general-anesthesia/?sc=c6502 Mon, 10 Jun 2024 11:00:00 EST All Journal News,Clinical Trials,Neuro,Surgery,Grant Funded News,JAMA Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2024/06/05/6660c1ce2df32_Collaboration2.png&width=100&height=150" alt="Newswise image" />New research from Washington University School of Medicine in St. Louis and other institutions supports earlier findings that indicate that anesthesia is no more hazardous for the brain at higher doses than at lower doses. /articles//images/uploads/2024/06/05/6660c1ce2df32_Collaboration2.png Washington University in St. Louis Hormone-free barrier contraceptive undergoing clinical trial at UC Davis Health /articles/hormone-free-barrier-contraceptive-undergoing-clinical-trial-at-uc-davis-health/?sc=c6502 /articles/hormone-free-barrier-contraceptive-undergoing-clinical-trial-at-uc-davis-health/?sc=c6502 Thu, 06 Jun 2024 10:30:38 EST Clinical Trials,Fertility,OBGYN,Women's Health Medical News Clinical Trials <img src="/legacy/image.php?image=/images/uploads/2024/06/05/6660e5241bf65_OvapreneandHand.png&width=100&height=150" alt="Newswise image" />The UC Davis Department of Obstetrics and Gynecology is recruiting potential participants for a clinical trial of an investigational hormone-free monthly intravaginal method of contraception. /articles//images/uploads/2024/06/05/6660e5241bf65_OvapreneandHand.png UC Davis Health Breakthroughs in Breast Cancer: Susan G. Komen(R) Scholars and Studies Highlighted at ASCO 2024 /articles/breakthroughs-in-breast-cancer-susan-g-komen-r-scholars-and-studies-highlighted-at-asco-2024/?sc=c6502 /articles/breakthroughs-in-breast-cancer-susan-g-komen-r-scholars-and-studies-highlighted-at-asco-2024/?sc=c6502 Thu, 06 Jun 2024 10:05:11 EST All Journal News,ASCO Meeting News,Cancer,Clinical Trials,ASCO Meeting News Medical News Research Results Scholars and studies funded by Susan G. Komen(R), the world's leading breast cancer organization, showcased cutting-edge breast cancer research aimed at advancing the field at the ASCO Annual Meeting 2024. Organized by the American Society of Clinical Oncology, this premier conference annually convenes over 40,000 oncologists and stakeholders worldwide. Susan G. Komen Groundbreaking LLNL and BridgeBio Oncology Therapeutics collaboration announces start of human trials for supercomputing-discovered cancer drug /articles/groundbreaking-llnl-and-bridgebio-oncology-therapeutics-collaboration-announces-start-of-human-trials-for-supercomputing-discovered-cancer-drug/?sc=c6502 /articles/groundbreaking-llnl-and-bridgebio-oncology-therapeutics-collaboration-announces-start-of-human-trials-for-supercomputing-discovered-cancer-drug/?sc=c6502 Thu, 06 Jun 2024 10:00:00 EST Artificial Intelligence,Biotech,Cancer,Clinical Trials,Supercomputing Medical News,Science News Research Results <img src="/legacy/image.php?image=/images/uploads/2024/06/05/6660db4836820_BridgeBiorelease-computing1280px.jpg&width=100&height=150" alt="Newswise image" />In a substantial milestone for supercomputing-aided drug design, Lawrence Livermore National Laboratory (LLNL) and BridgeBio Oncology Therapeutics (BridgeBio) today announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer. /articles//images/uploads/2024/06/05/6660db4836820_BridgeBiorelease-computing1280px.jpg,/images/uploads/2024/06/05/6660db70b5ac5_secondphoto.jpeg Lawrence Livermore National Laboratory Drug Used to Treat Eczema May Provide Relief for Patients with Intensely Itchy Skin Diseases /articles/drug-used-to-treat-eczema-may-provide-relief-for-patients-with-intensely-itchy-skin-diseases/?sc=c6502 /articles/drug-used-to-treat-eczema-may-provide-relief-for-patients-with-intensely-itchy-skin-diseases/?sc=c6502 Wed, 05 Jun 2024 17:05:10 EST All Journal News,Clinical Trials,Dermatology,Drugs and Drug Abuse,JAMA Medical News Research Results <img src="/legacy/image.php?image=https://www.medschool.umaryland.edu/media/som/news/2024/Itchy-Skin-Banner.jpg&width=100&height=150" alt="Newswise image" />Clinical Trial Finds Oral Medication Significantly Reduced Prurigo Nodularis and Chronic Pruritus of Unknown Origin Symptoms A drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according to a new study published in JAMA Dermatology. /articles/https://www.medschool.umaryland.edu/media/som/news/2024/Itchy-Skin-Banner.jpg University of Maryland School of Medicine UC San Diego Health First in Region to Provide Novel Therapy for Melanoma /articles/uc-san-diego-health-first-in-region-to-provide-novel-therapy-for-melanoma/?sc=c6502 /articles/uc-san-diego-health-first-in-region-to-provide-novel-therapy-for-melanoma/?sc=c6502 Tue, 04 Jun 2024 13:05:25 EST Cancer,Clinical Trials,Dermatology Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2024/06/04/665f4f0f6998b_T-cell-illustration-GettyImages-486570034-060324.jpg&width=100&height=150" alt="Newswise image" />Breakthrough one-time cancer treatment option for select patients with metastatic melanoma and solid tumors now offered at UC San Diego Health. /articles//images/uploads/2024/06/04/665f4f0f6998b_T-cell-illustration-GettyImages-486570034-060324.jpg UC San Diego Health Endocrine Society Guideline recommends healthy adults under the age of 75 take the recommended daily allowance of vitamin D /articles/endocrine-society-guideline-recommends-healthy-adults-under-the-age-of-75-take-the-recommended-daily-allowance-of-vitamin-d/?sc=c6502 /articles/endocrine-society-guideline-recommends-healthy-adults-under-the-age-of-75-take-the-recommended-daily-allowance-of-vitamin-d/?sc=c6502 Mon, 03 Jun 2024 08:00:00 EST FASEB channel,Aging,All Journal News,Clinical Trials,Healthcare,Nutrition,FASEB channel,Top Clipped Stories Medical News Research Results Healthy adults under the age of 75 are unlikely to benefit from taking more than the daily intake of vitamin D recommended by the Institutes of Medicine (IOM) and do not require testing for vitamin D levels, according to a new Clinical Practice Guideline issued today by the Endocrine Society. Endocrine Society Clinical trials show promise in treating central nervous system lymphoma, breast cancer, and glioblastoma /articles/clinical-trials-show-promise-in-treating-central-nervous-system-lymphoma-breast-cancer-and-glioblastoma/?sc=c6502 /articles/clinical-trials-show-promise-in-treating-central-nervous-system-lymphoma-breast-cancer-and-glioblastoma/?sc=c6502 Sat, 01 Jun 2024 08:05:56 EST Medical Meetings,ASCO Meeting News,Cancer,Clinical Trials,Neuro,ASCO Meeting News,Top Hit Stories Medical News Research Results Dana-Farber Cancer Institute researchers are leading 3 separate studies with encouraging results in treating patients with central nervous system (CNS) lymphoma, breast cancer, and glioblastoma. These findings are among more than 80 studies presented at ASCO that are led by Dana-Farber-affiliated researchers. Dana-Farber Cancer Institute Experimental Therapy Shows Promise in Pancreatic Cancer Clinical Trial /articles/experimental-therapy-shows-promise-in-pancreatic-cancer-clinical-trial/?sc=c6502 /articles/experimental-therapy-shows-promise-in-pancreatic-cancer-clinical-trial/?sc=c6502 Sat, 01 Jun 2024 08:00:00 EST Cancer,Clinical Trials,Immunology Medical News Clinical Trials Clinicians at Georgetown University's Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a phase 2 clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda). Lombardi Comprehensive Cancer Center at Georgetown University Study Reveals Worse Clinical Outcomes in Breast Cancer Patients Who Reported Higher Pain and Stress /articles/study-reveals-worse-clinical-outcomes-in-breast-cancer-patients-who-reported-higher-pain-and-stress/?sc=c6502 /articles/study-reveals-worse-clinical-outcomes-in-breast-cancer-patients-who-reported-higher-pain-and-stress/?sc=c6502 Thu, 30 May 2024 16:25:45 EST ASCO Meeting News,Cancer,Clinical Trials,ASCO Meeting News,Top Hit Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2024/05/30/6658d9be7889c_GandhiShipraAugust062018.jpg&width=100&height=150" alt="Newswise image" />Secondary analyses of a phase 3 clinical trial have revealed that breast cancer patients who reported high levels of pain and stress were more likely than their study peers to experience worse invasive disease-free survival (iDFS) and worse overall survival (OS). /articles//images/uploads/2024/05/30/6658d9be7889c_GandhiShipraAugust062018.jpg Roswell Park Comprehensive Cancer Center Pathways Study Genotype Data, Alliance A011502 Secondary Analysis Headline Roswell Park ASCO24 Presentations /articles/pathways-study-genotype-data-alliance-a011502-secondary-analysis-headline-roswell-park-asco24-presentations/?sc=c6502 /articles/pathways-study-genotype-data-alliance-a011502-secondary-analysis-headline-roswell-park-asco24-presentations/?sc=c6502 Fri, 24 May 2024 16:05:13 EST ASCO Meeting News,Cancer,Clinical Trials,ASCO Meeting News,Medical Meetings Medical News Research Results New insights on improving clinical outcomes and quality of life among breast cancer patients highlight the slate of new research presentations Roswell Park Comprehensive Cancer Center experts will deliver at the American Society of Clinical Oncology (ASCO) Annual Meeting at McCormick Place in Chicago next week. Roswell Park Comprehensive Cancer Center Donepezil Does Not Improve Chemotherapy-Related Cognitive Impairment /articles/donepezil-does-not-improve-chemotherapy-related-cognitive-impairment/?sc=c6502 /articles/donepezil-does-not-improve-chemotherapy-related-cognitive-impairment/?sc=c6502 Tue, 21 May 2024 09:05:09 EST All Journal News,Cancer,Clinical Trials,Cognition and Learning,Healthcare Medical News Research Results Researchers at Wake Forest University School of Medicine conducted a Phase III randomized, placebo-controlled trial to test donepezil, a cognitive-enhancing medicine used in the treatment of Alzheimer's disease. The research team found that donepezil did not improve memory or other cognitive functions in survivors with cancer-related cognitive impairment. Wake Forest University School of Medicine HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis after ACL Revision Surgery /articles/hss-launches-clinical-trial-to-address-post-traumatic-osteoarthritis-after-acl-revision-surgery/?sc=c6502 /articles/hss-launches-clinical-trial-to-address-post-traumatic-osteoarthritis-after-acl-revision-surgery/?sc=c6502 Mon, 20 May 2024 10:00:41 EST Clinical Trials,Surgery Medical News Feature Up to 18% of patients undergoing ACL reconstruction experience graft failure and require revision surgery, which is known to increase the risk of developing post-traumatic osteoarthritis (PTOA). Hospital for Special Surgery Clinical trial testing licorice root for prostate cancer begins this spring /articles/clinical-trial-testing-licorice-root-for-prostate-cancer-begins-this-spring/?sc=c6502 /articles/clinical-trial-testing-licorice-root-for-prostate-cancer-begins-this-spring/?sc=c6502 Mon, 20 May 2024 08:55:54 EST Cancer,Clinical Trials,Healthcare,Public Health Medical News Clinical Trials The University of Illinois Chicago study will be the first to assess whether the natural product has anti-cancer effects that could benefit patients as they await surgical treatment. University of Illinois Chicago Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog /articles/mira-pharmaceuticals-advances-preclinical-trials-towards-an-ind-submission-this-year-for-ketamir-2-a-differentiated-oral-ketamine-analog/?sc=c6502 /articles/mira-pharmaceuticals-advances-preclinical-trials-towards-an-ind-submission-this-year-for-ketamir-2-a-differentiated-oral-ketamine-analog/?sc=c6502 Mon, 20 May 2024 08:05:35 EST All Journal News,Clinical Trials,Mental Health,Neuro,Pain,Pharmaceuticals Medical News Research Results MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and neuropsychiatric disorders, announced that it has advanced new preclinical studies using Ketamir-2, its differentiated oral ketamine analog, towards clinical development for the treatment of severe post-traumatic stress disorder (PTSD) and other leading mental health disorders and neuropathic pain indications. MIRA Pharmaceuticals, Inc. Tricking the Brain's inner GPS: Grid cells responses to the illusion of self-location /articles/tricking-the-brain-s-inner-gps-grid-cells-responses-to-the-illusion-of-self-location/?sc=c6502 /articles/tricking-the-brain-s-inner-gps-grid-cells-responses-to-the-illusion-of-self-location/?sc=c6502 Mon, 20 May 2024 00:00:21 EST Cell Biology,Clinical Trials,Technology,PNAS,All Journal News,Top Hit Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2024/05/14/66431562434b7_Figure1.jpg&width=100&height=150" alt="Newswise image" />Dr. Hyuk-June Moon from the Bionics Research Center at the Korea Institute of Science and Technology (KIST), in collaboration with Prof. Olaf Blanke's team at the Swiss Federal Institute of Technology Lausanne (EPFL), has successfully induced self-location illusions with multi-sensory virtual reality (VR) in the MRI scanner and observed corresponding changes in the human brain's grid cell activity. /articles//images/uploads/2024/05/14/66431562434b7_Figure1.jpg,/images/uploads/2024/05/14/664315655014e_Figure2.jpg,/images/uploads/2024/05/14/664315689f78d_Figure3.jpg National Research Council of Science and Technology Ochsner Health Highlights Innovative Non-Opioid Pain Therapy Candidate Publication /articles/ochsner-health-highlights-innovative-non-opioid-pain-therapy-candidate-publication/?sc=c6502 /articles/ochsner-health-highlights-innovative-non-opioid-pain-therapy-candidate-publication/?sc=c6502 Thu, 16 May 2024 11:05:45 EST Clinical Trials,All Journal News,Scientific Reports Medical News Research Results A recent publication in Scientific Reports unveils a potentially groundbreaking non-opioid pain treatment developed by a team led by Dr. Hernan Bazan. Ochsner Health